多中心临床研究与人性化小鼠模型提示肾小球系膜IgA2沉积参与IgA肾病发病
研究通过激光捕获显微切割联合质谱(LCM/MS)分析14例IgA肾病患者和10例健康供肾活检组织,并在三个中国临床中心对161例活检证实的IgA肾病病例进行多中心免疫荧光分析,同时构建人性化IgA1/IgA2小鼠模型诱导IgA肾病。结果显示超过98%的IgA肾病病例存在系膜IgA2沉积,其强度与慢性病变(牛津T病变)和肾功能障碍显著相关,人性化IgA2小鼠出现肾小管萎缩和更强的补体C3激活及间质巨噬细胞浸润。结论提示IgA2参与IgA肾病发病,应纳入未来研究。
要点
- 超过98%的IgA肾病病例存在系膜IgA2沉积,且强度与慢性病变和肾功能障碍相关。
- 人性化IgA2小鼠出现肾小管萎缩、更强的肾小球补体C3激活和间质巨噬细胞浸润。
- IgA2应被纳入未来IgA肾病发病机制研究,超越以IgA1为中心的模式。
核心结论
- IgA2能够沉积于肾小球系膜、激活补体并诱导独特的组织病理学损伤模式,参与IgA肾病发病。
研究设计与样本
- 对14例IgA肾病患者和10例健康供肾活检组织进行LCM/MS分析。
- 在三个中国临床中心对161例活检证实的IgA肾病病例进行多中心免疫荧光分析。
- 构建人性化IgA1/IgA2小鼠模型,腹腔注射干酪乳杆菌细胞壁提取物加完全弗氏佐剂诱导IgA肾病。
主要发现
- LCM/MS在IgA肾病肾小球中检测到IgA2(m1)和IgA2(m2),证实IgA2沉积但丰度低于IgA1。
- 多中心免疫荧光显示超过98%的IgA肾病病例存在系膜IgA2,强度与牛津T病变相关(ρ=0.237)。
- 系膜IgA2强度与eGFR显著负相关(r=-0.272)。
- 人性化IgA2小鼠出现肾小管萎缩(面积16%-22%),而人性化IgA1小鼠无此表现。
- 与IgA1小鼠相比,IgA2小鼠肾小球补体C3激活更强且间质巨噬细胞浸润更明显。
临床怎么用
- 肾内科医生应关注IgA2在IgA肾病中的潜在致病作用,未来研究可纳入IgA2相关指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: While IgA1 is well established as pathogenic in IgA nephropathy (IgAN), IgA2's role remains controversial. The most notable difference between IgA1 and IgA2 lies in the hinge region: IgA2 lacks a 13-amino acid segment unique in IgA1, which contains nine serine and threonine residues that can be O-glycosylated. Here, we investigated the role of IgA2 in the development of IgAN. METHODS: To characterize glomerular IgA2 deposition in IgAN, we performed laser capture microdissection coupled with mass spectrometry (LCM/MS) on kidney biopsies from 14 patients with IgAN and 10 healthy donors. Additionally, multicenter immunofluorescence analysis was conducted using validated subclass-specific antibodies on 161 biopsy-proven IgAN cases from three Chinese clinical centers. To establish IgA2's pathogenicity, we generated humanized IgA1/IgA2 mouse models and induced IgAN via intraperitoneal administration of Lactobacillus casei cell wall extract with complete Freund's adjuvant. RESULTS: LCM/MS detected both IgA2(m1) and IgA2(m2) in IgAN glomeruli, confirming IgA2 deposition despite lower abundance than IgA1. Multicenter kidney immunofluorescence staining revealed mesangial IgA2 in over 98% of IgAN cases, with significant intensity correlating with chronic lesions (Oxford T lesion: ρ of 0.237) and significant kidney dysfunction (eGFR: r of -0.272). The humanized IgA2 model exhibited IgA2 mesangial deposition and developed tubular atrophy (16%-22% area), absent in humanized IgA1 mice. IgA2 mice also exhibited stronger glomerular complement C3 activation and interstitial macrophage infiltration compared with IgA1 mice. CONCLUSIONS: Our study highlights the role of IgA2 in IgAN development, demonstrating its capacity for glomerular deposition, complement activation, and induction of distinct histopathological injury patterns. These findings extend the IgA1-centric paradigm, indicating that IgA2 should be incorporated into future investigations of IgAN.
引用
- Li R, Ma Y, Xie X, et al. Evidence from multicenter clinical studies and humanized mouse models indicates that glomerular mesangial IgA2 deposition contributes to the pathogenesis of IgA nephropathy. Kidney Int. 2026. PMID: 41833637. doi:10.1016/j.kint.2026.02.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。